| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |